Study shows an immune signaling protein, interleukin-1β (IL-1β), is made and released by pancreatic tumor cells to reduce anti-cancer immune responses, which promoted the growth of pancreatic ductal adenocarcinoma or PDA, a form of cancer that is usually deadly within two years.
Read the Full Article from NewsMedicalLifeScience